参考文献/References:
[1] Fang H, Judd RL. Adiponectin Regulation and Function. Compr Physiol. 2018. 8(3): 1031-1063.
[2] Wang L. CTRP4: a new member of the adipocytokine family. Cell Mol Immunol. 2017. 14(10): 868-870.
[3] 雷虹, 张洁, 王瑾瑜, 吴立玲. 补体C1q/肿瘤坏死因子相关蛋白家族研究进展. 生理科学进展. 2015. 46(01): 43-48.
[4] Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, et al. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J. 2009. 23(1): 241-258.
[5] Zhang C, Zhou N, Qiu P, et al. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease[J]. Cytokine, 2018,110:52-57.
[6] Yu XH, Zhang DW, Zheng XL, Tang CK. C1q tumor necrosis factor-related protein 9 in atherosclerosis: Mechanistic insights and therapeutic potential. Atherosclerosis. 2018. 276: 109-116.
[7] Rezabakhsh A, Sadeghpour Y, Ghaderi S, Rahbarghazi R, Geranmayeh MH. CTRP9: An emerging potential anti-aging molecule in brain. Cell Signal. 2020. 73: 109694.
[8] Yuan Y, Lau WB, Su H, et al. C1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform. Am J Physiol Endocrinol Metab. 2015. 308(10): E891-E898.
[9] Niemann B, Li L, Siegler D, et al. CTRP9 Mediates Protective Effects in Cardiomyocytes via AMPK- and Adiponectin Receptor-Mediated Induction of Anti-Oxidant Response. Cells. 2020. 9(5).
[10] Seldin MM, Tan SY, Wong GW. Metabolic function of the CTRP family of hormones. Rev Endocr Metab Disord. 2014. 15(2): 111-123.
[11] Hwang YC, Woo Oh S, Park SW, et al. Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans[J]. Int J Obes (Lond), 2014,38(9):1207-1212.
[12] Asada M, Morioka T, Yamazaki Y, et al. Plasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients with Type 2 Diabetes without Renal Dysfunction[J]. J Diabetes Res, 2016,2016:8624313.
[13] Lustig Y, Hemi R, Kanety H. Regulation and function of adiponectin receptors in skeletal muscle. Vitam Horm. 2012. 90: 95-123.
[14] Zhao L, Zhang JH, Sherchan P, et al. Administration of rCTRP9 Attenuates Neuronal Apoptosis Through AdipoR1/PI3K/Akt Signaling Pathway after ICH in Mice. Cell Transplant. 2019. 28(6): 756-766.
[15] Zheng Q, Yuan Y, Yi W, et al. C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway. Arterioscler Thromb Vasc Biol. 2011. 31(11): 2616-2623.
[16] Takahata C, Miyoshi Y, Irahara N, Taguchi T, Tamaki Y, Noguchi S. Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett. 2007. 250(2): 229-236.
[17] Takemura Y, Osuga Y, Yamauchi T, et al. Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology. 2006. 147(7): 3203-3210.
[18] Miyazaki T, Bub JD, Uzuki M, Iwamoto Y. Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem Biophys Res Commun. 2005. 333(1): 79-87.
[19] Barb D, Williams CJ, Neuwirth AK, Mantzoros CS. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr. 2007. 86(3): s858-s866.
[20] Otani K, Kitayama J, Kamei T, et al. Adiponectin receptors are downregulated in human gastric cancer. J Gastroenterol. 2010. 45(9): 918-927.
[21] Jie C, Xuan W, Feng HD, et al. AdipoR2 inhibits human glioblastoma cell growth through the AMPK/mTOR pathway. Eur J Med Res. 2021. 26(1): 28.
[22] Cao ZQ, Wang Z, Leng P. Aberrant N-cadherin expression in cancer. Biomed Pharmacother. 2019. 118: 109320.
[23] Radice GL. N-cadherin-mediated adhesion and signaling from development to disease: lessons from mice. Prog Mol Biol Transl Sci. 2013. 116: 263-289.
[24] Li J, Patel VV, Kostetskii I, et al. Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis. Circ Res. 2005. 97(5): 474-481.
[25] Mistry T, Digby JE, Chen J, Desai KM, Randeva HS. The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun. 2006. 348(3): 832-838.
[26] Duan J, Yin Y, Cui J, et al. Chikusetsu Saponin IVa Ameliorates Cerebral Ischemia Reperfusion Injury in Diabetic Mice via Adiponectin-Mediated AMPK/GSK-3β Pathway In Vivo and In Vitro. Mol Neurobiol. 2016. 53(1): 728-743.
[27] Gasbarrino K, Hafiane A, Zheng H, Daskalopoulou SS. Intensive Statin Therapy Compromises the Adiponectin-AdipoR Pathway in the Human Monocyte-Macrophage Lineage. Stroke. 2019. 50(12): 3609-3617.
[28] Shen X, Li H, Li W, Wu X, Ding X. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs. Mol Cell Endocrinol. 2012. 363(1-2): 27-35.
[29] Shen X, Li H, Li W, Wu X, Sun Z, Ding X. Telmisartan ameliorates adipoR1 and adipoR2 expression via PPAR-γ activation in the coronary artery and VSMCs. Biomed Pharmacother. 2017. 95: 129-136.
[30] van Stijn CM, Kim J, Lusis AJ, Barish GD, Tangirala RK. Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response. FASEB J. 2015. 29(2): 636-649.
[31] Zhang G, Yang L, Han Y, et al. Abnormal Macrophage Polarization in Patients with Myelodysplastic Syndrome[J]. Mediators Inflamm, 2021,2021:9913382.
[32] 马雅楠, 金晓雪, 刘德敏,等. CTRP9对冠心病合并2型糖尿病患者冠状动脉钙化的预测价值[J]. 心血管病学进展,2022,43(06):572-576.
[33] Miyatake N, Adachi H, Nomura-Nakayama K, et al. Circulating CTRP9 correlates with the prevention of aortic calcification in renal allograft recipients. PLoS One. 2020. 15(1): e0226526.
[34] Moradi N, Fadaei R, Emamgholipour S, et al. Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease. PLoS One. 2018. 13(1): e0192159.
[35] Liu Q, Zhang H, Lin J, et al. C1q/TNF-related protein 9 inhibits the cholesterol-induced Vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP-dependent kinase. J Cell Mol Med. 2017. 21(11): 2823-2836.
[36] Uemura Y, Shibata R, Ohashi K, et al. Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation. FASEB J. 2013. 27(1): 25-33.
[37] Kambara T, Ohashi K, Shibata R, et al. CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism. J Biol Chem. 2012. 287(23): 18965-18973.
[38] Zhang P, Huang C, Li J, et al. Globular CTRP9 inhibits oxLDL-induced inflammatory response in RAW 264.7 macrophages via AMPK activation. Mol Cell Biochem. 2016. 417(1-2): 67-74.
[39] Song CX, Chen JY, Li N, Guo Y. CTRP9 Enhances Efferocytosis in Macrophages via MAPK/Drp1-Mediated Mitochondrial Fission and AdipoR1-Induced Immunometabolism. J Inflamm Res. 2021. 14: 1007-1017.
[40] Zhao W, Kong F, Gong X, Guo Z, Zhao L, Wang S. Activation of AdipoR1 with rCTRP9 Preserves BBB Integrity through the APPL1/AMPK/Nrf2 Signaling Pathway in ICH Mice. Oxid Med Cell Longev. 2021. 2021: 2801263.
[41] Wang B, Li Y, Hu S, Peng K. C1q/tumor necrosis factor-related protein 9 protects cultured chondrocytes from IL-1β-induced inflammatory injury by inhibiting NLRP3 inflammasome activation via the AdipoR1/AMPK axis. Environ Toxicol. 2022 .
[42] Yan W, Guo Y, Tao L, et al. C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects Against Ischemic Heart Injury via Multiple Novel Signaling Pathways. Circulation. 2017. 136(22): 2162-2177.
[43] Ishimine H, Yamakawa N, Sasao M, et al. N-Cadherin is a prospective cell surface marker of human mesenchymal stem cells that have high ability for cardiomyocyte differentiation. Biochem Biophys Res Commun. 2013. 438(4): 753-759.
[44] Ye JJ, Bian X, Lim J, Medzhitov R. Adiponectin and related C1q/TNF-related proteins bind selectively to anionic phospholipids and sphingolipids. Proc Natl Acad Sci USA. 2020. 117(29): 17381-17388.
[45] Takemura Y, Ouchi N, Shibata R, et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest. 2007. 117(2): 375-386.
[46] Yamauchi T, Iwabu M, Okada-Iwabu M, et al. Adiponectin receptors: a review of their structure, function and how they work[J]. Best Pract Res Clin Endocrinol Metab, 2014,28(1):15-23.
[47] Zhao D, Feng P, Sun Y, et al. Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis. Cell Death Dis. 2018. 9(7): 723.
[48] Klonisch T, Glogowska A, Thanasupawat T, et al. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells. Br J Pharmacol. 2017. 174(10): 1025-1033.